Related Experiment Video

Updated: Mar 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

Wenwen Du1,2, Min Yang3,4, Abbey Turner5

  • 1Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. daisy910917@163.com.

International Journal of Molecular Sciences
|March 17, 2017
PubMed

Insights

Targeting T cell immunoglobulin and mucin domain 3 (TIM-3) offers a promising strategy to enhance cancer immunotherapy beyond current checkpoint blockade therapies. Further research into TIM-3

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Cancer immunotherapy, particularly checkpoint blockade targeting CTLA-4 and PD-1, has shown success but benefits only a subset of patients.
  • T cell immunoglobulin and mucin domain 3 (TIM-3) plays a role in immune tolerance across various conditions, including tumor immunity.
  • TIM-3 is recognized as a potential target for improving existing immunotherapies.

Purpose of the Study:

  • To review key evidence supporting the immune regulatory role of TIM-3 in cancer.
  • To discuss the potential mechanisms of action for TIM-3 in immune suppression.
  • To highlight the need for mechanistic studies to enable effective TIM-3 targeting in cancer immunotherapy.

Main Methods:

  • Literature review summarizing experimental data on TIM-3 function.
  • Analysis of evidence for TIM-3's role in immune tolerance and tumor immunity.
  • Discussion of potential mechanisms underlying TIM-3's immune suppressive effects.

Main Results:

  • Substantial experimental data indicates an immune suppressive function of TIM-3 in vivo.
  • TIM-3 is implicated in mediating immune tolerance in models of cancer.
  • The precise mechanisms by which TIM-3 exerts its immune suppressive effects require further elucidation.

Conclusions:

  • Targeting TIM-3 presents a promising avenue for advancing cancer immunotherapy.
  • In-depth mechanistic studies are crucial for developing effective TIM-3-based therapies.
  • Understanding TIM-3 mechanisms will inform rational design of combination therapies with other checkpoint inhibitors.
Keywords:
T cell subsetsTIM-3antitumor immune responsestumor microenvironment

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.6K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K